Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mozobil in WHIMS Syndrome
NCT00967785Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2010
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in WHIM syndrome (WHIM), sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2010; status: completed.
02
Drugs
plerixafor
03
Conditions
WHIM syndrome (WHIM)
Beyond the preview
Go deeper on NCT00967785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967785.